Opportunity
Federal Register #FDA-2026-N-1199
FDA Issues Debarment Order for Drug Import Violations (No Procurement)
Posted
July 24, 2026
Identifier
FDA-2026-N-1199
This notice is a regulatory enforcement action by the Food and Drug Administration (FDA), not a procurement opportunity. - Government Buyer: - Department of Health and Human Services (HHS) - Food and Drug Administration (FDA) - Action: Final debarment order issued against Francis Esteban Matos - Purpose: Prohibits Mr. Matos from importing or offering for import any drug into the United States for five years - Basis: Conviction for felony offenses involving illegal importation and distribution of misbranded pharmaceutical drugs - No OEMs, vendors, products, or purchase quantities are mentioned - No products or services are being requested or procured - This is not a solicitation, contract award, or request for goods/services
Description
The Food and Drug Administration (FDA) is issuing a final debarment order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Francis Esteban Matos for 5 years from importing or offering for import any drug into the United States. This action is based on Mr. Matos's conviction of a felony related to the importation of misbranded drugs into interstate commerce. Mr. Matos operated a business that obtained and distributed pharmaceutical drugs without a license and without requiring prescriptions, violating multiple provisions of the FD&C Act. He was given notice and an opportunity for a hearing but failed to respond, resulting in a waiver of his right to a hearing.